Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.030
+0.010 (0.33%)
Jan 21, 2026, 4:08 PM HKT

HKG:1349 Statistics

Total Valuation

HKG:1349 has a market cap or net worth of HKD 7.89 billion. The enterprise value is 6.68 billion.

Market Cap7.89B
Enterprise Value 6.68B

Important Dates

The next estimated earnings date is Tuesday, March 31, 2026.

Earnings Date Mar 31, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:1349 has 1.04 billion shares outstanding. The number of shares has decreased by -24.84% in one year.

Current Share Class 326.00M
Shares Outstanding 1.04B
Shares Change (YoY) -24.84%
Shares Change (QoQ) -69.39%
Owned by Insiders (%) 24.44%
Owned by Institutions (%) 2.92%
Float 416.18M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.14
PB Ratio 3.20
P/TBV Ratio 3.29
P/FCF Ratio 72.68
P/OCF Ratio 48.23
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -97.57
EV / Sales 8.59
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 61.58

Financial Position

The company has a current ratio of 8.68, with a Debt / Equity ratio of 0.01.

Current Ratio 8.68
Quick Ratio 8.40
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF 0.16
Interest Coverage -152.80

Financial Efficiency

Return on equity (ROE) is -2.73% and return on invested capital (ROIC) is -2.83%.

Return on Equity (ROE) -2.73%
Return on Assets (ROA) -2.58%
Return on Invested Capital (ROIC) -2.83%
Return on Capital Employed (ROCE) -4.59%
Revenue Per Employee 842,633
Profits Per Employee -74,208
Employee Count925
Asset Turnover 0.28
Inventory Turnover 1.88

Taxes

Income Tax -34.69M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +31.88% in the last 52 weeks. The beta is -0.02, so HKG:1349's price volatility has been lower than the market average.

Beta (5Y) -0.02
52-Week Price Change +31.88%
50-Day Moving Average 3.00
200-Day Moving Average 3.24
Relative Strength Index (RSI) 51.13
Average Volume (20 Days) 1,563,391

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:1349 had revenue of HKD 777.75 million and -68.49 million in losses. Loss per share was -0.08.

Revenue777.75M
Gross Profit 697.49M
Operating Income -114.82M
Pretax Income -103.40M
Net Income -68.49M
EBITDA -55.06M
EBIT -114.82M
Loss Per Share -0.08
Full Income Statement

Balance Sheet

The company has 1.22 billion in cash and 17.44 million in debt, with a net cash position of 1.21 billion or 1.16 per share.

Cash & Cash Equivalents 1.22B
Total Debt 17.44M
Net Cash 1.21B
Net Cash Per Share 1.16
Equity (Book Value) 2.47B
Book Value Per Share 2.38
Working Capital 1.48B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 163.53 million and capital expenditures -55.00 million, giving a free cash flow of 108.52 million.

Operating Cash Flow 163.53M
Capital Expenditures -55.00M
Free Cash Flow 108.52M
FCF Per Share 0.10
Full Cash Flow Statement

Margins

Gross margin is 89.68%, with operating and profit margins of -14.76% and -8.81%.

Gross Margin 89.68%
Operating Margin -14.76%
Pretax Margin -13.30%
Profit Margin -8.81%
EBITDA Margin -7.08%
EBIT Margin -14.76%
FCF Margin 13.95%

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 2.22%.

Dividend Per Share 0.07
Dividend Yield 2.22%
Dividend Growth (YoY) -67.04%
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 24.84%
Shareholder Yield 27.05%
Earnings Yield -0.87%
FCF Yield 1.38%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:1349 has an Altman Z-Score of 21.65 and a Piotroski F-Score of 4.

Altman Z-Score 21.65
Piotroski F-Score 4